Mains Practice Questions

In a tragic incident, more than twenty children in a state district lost their lives after consuming a widely used cough syrup later found to be adulterated. Dr Ananya, a senior health officer posted in the state’s Drug Control Department, has been tasked with investigating the matter and ensuring accountability.

As she delves into records, she uncovers alarming lapses in drug testing protocols, delayed inspections, and collusion between some local distributors and manufacturers. Parents and civil society groups are demanding immediate disclosure of investigation reports, punitive action against responsible parties, and systemic reforms to prevent recurrence.

Meanwhile, the state health department is under immense political pressure to manage public outrage and contain negative media coverage. Some senior officials subtly advise Dr Ananya to “handle the matter quietly” to avoid reputational damage to the government and influential stakeholders, warning that strict enforcement may jeopardise her career.

Junior officers involved in sample testing and reporting express fear of harassment, transfers, or legal consequences if they fully disclose the facts. At the same time, courts have taken suo motu cognisance, and multiple PILs have been filed seeking transparency in the investigation, compensation for affected families, and reforms in drug safety oversight.

Questions:

A. What ethical dilemmas confront Dr Ananya in this scenario?

B.  Evaluate the options available to her and their potential consequences.

C. Suggest the most appropriate course of action for Dr Ananya based on balancing administrative responsibility and citizen welfare.

D. Propose long-term systemic reforms to strengthen drug safety oversight.